212 related articles for article (PubMed ID: 36504796)
1. Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus.
Xu P; Yang Z; Du S; Hong Z; Zhong S
Front Microbiol; 2022; 13():1035941. PubMed ID: 36504796
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach.
Yang R; Yang H; Wei J; Li W; Yue F; Song Y; He X; Hu K
Front Pharmacol; 2021; 12():717652. PubMed ID: 34721017
[No Abstract] [Full Text] [Related]
3. Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology.
Su H; Wu G; Zhan L; Xu F; Qian H; Li Y; Zhu X
Evid Based Complement Alternat Med; 2022; 2022():5536266. PubMed ID: 35145559
[TBL] [Abstract][Full Text] [Related]
4. Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation.
Wei J; Zhao X; Long F; Tian K; Wu L
Gene; 2024 Jun; 912():148383. PubMed ID: 38493972
[TBL] [Abstract][Full Text] [Related]
5. Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration.
Li S; Feng T; Zhang Y; Shi Q; Wang W; Ren J; Shen G; Gu H; Luo C; Li Y
J Ethnopharmacol; 2024 Feb; 320():117467. PubMed ID: 37981112
[TBL] [Abstract][Full Text] [Related]
6. Lianhuaqingwen capsule inhibits influenza-induced bacterial adhesion to respiratory epithelial cells through down-regulation of cell adhesion molecules.
Du Q; Huang W; Zhao J; Zeng J; Zhang W; Huang X; Chen R; Jiang H; Xie Y; Wang Y; Zhong N; Wang X; Yang Z
J Ethnopharmacol; 2021 Nov; 280():114128. PubMed ID: 33872750
[TBL] [Abstract][Full Text] [Related]
7. Integrated network pharmacology and intestinal flora analysis to determine the protective effect of Xuanbai-Chengqi decoction on lung and gut injuries in influenza virus-infected mice.
Huo J; Wang T; Wei B; Shi X; Yang A; Chen D; Hu J; Zhu H
J Ethnopharmacol; 2022 Nov; 298():115649. PubMed ID: 35987410
[TBL] [Abstract][Full Text] [Related]
8. Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model.
Yang C; Wang Y; He J; Yan W; Jiang H; Chen Q; Li L; Yang Z
Evid Based Complement Alternat Med; 2020; 2020():3196375. PubMed ID: 32565852
[TBL] [Abstract][Full Text] [Related]
9. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.
Hong L; He M; Li S; Zhao J
Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival.
Cao JF; Gong Y; Wu M; Xiong L; Chen S; Huang H; Zhou X; Peng YC; Shen XF; Qu J; Wang YL; Zhang X
Front Cell Infect Microbiol; 2022; 12():1044770. PubMed ID: 36506032
[TBL] [Abstract][Full Text] [Related]
11. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection.
Gao D; Niu M; Wei SZ; Zhang CE; Zhou YF; Yang ZW; Li L; Wang JB; Zhang HZ; Zhang L; Xiao XH
Front Pharmacol; 2020; 11():746. PubMed ID: 32523531
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism and material basis of
Yan H; Zou C
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):20-30. PubMed ID: 33509749
[TBL] [Abstract][Full Text] [Related]
15. The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis.
Hu C; He B; Gong F; Liang M; Zhao D; Zhang G
Front Pharmacol; 2022; 13():764774. PubMed ID: 35153773
[No Abstract] [Full Text] [Related]
16. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.
Li L; Wang X; Guo X; Li Y; Song Q; Li A
Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen).
Chen S; Yang X; Wei Z; Zhang Y; Huang Y; Shi Z; Zhang Z; Wang J; Zhang H; Ma J; Xiao X; Niu M
Pharm Biol; 2021 Dec; 59(1):537-545. PubMed ID: 33941036
[TBL] [Abstract][Full Text] [Related]
18. [Network pharmacological analysis and experimental study of Pulsatilla chinensis against inflammatory injury caused by pneumonia in mice infected with influenza virus FM_1].
Liu T; Xu HR; Wang CX; Cao HY; Li M; Yao XW; Yu HY; Zhang LY; Liu GX; Liu C; Hao DD; Liu FY
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(22):5867-5876. PubMed ID: 34951177
[TBL] [Abstract][Full Text] [Related]
19. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
Ma Q; Huang W; Zhao J; Yang Z
J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
[TBL] [Abstract][Full Text] [Related]
20. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study.
Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y
Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
